| DB00102 | Becaplermin | approved, investigational | yes | | Details |
| DB00619 | Imatinib | approved | unknown | antagonist | Details |
| DB00398 | Sorafenib | approved, investigational | yes | antagonist | Details |
| DB01254 | Dasatinib | approved, investigational | unknown | antagonist | Details |
| DB01268 | Sunitinib | approved, investigational | yes | inhibitor | Details |
| DB05014 | XL999 | investigational | unknown | | Details |
| DB05146 | XL820 | investigational | unknown | | Details |
| DB06589 | Pazopanib | approved | yes | inhibitor | Details |
| DB06595 | Midostaurin | approved, investigational | yes | antagonistinhibitor | Details |
| DB08896 | Regorafenib | approved | yes | inhibitor | Details |
| DB09079 | Nintedanib | approved | yes | inhibitor | Details |
| DB09283 | Trapidil | experimental | unknown | antagonist | Details |
| DB09221 | Polaprezinc | experimental | unknown | agonist | Details |
| DB10770 | Foreskin fibroblast (neonatal) | approved | unknown | agonist | Details |
| DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
| DB12147 | Erdafitinib | approved, investigational | unknown | substrate | Details |
| DB12978 | Pexidartinib | approved, investigational | unknown | inhibitor | Details |
| DB14840 | Ripretinib | approved | yes | inhibitor | Details |
| DB15822 | Pralsetinib | approved, investigational | unknown | inhibitor | Details |